AG
BLUE

Artal Group’s bluebird bio BLUE Stock Holding History

Artal Group’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-7,720
Closed -$4.6M – 135
2020
Q1 		$4.6M Hold
7,720
– – 0.19% 76
2019
Q4 		$8.78M Hold
7,720
– – 0.34% 49
2019
Q3 		$9.18M Hold
7,720
– – 0.37% 51
2019
Q2 		$12.7M Hold
7,720
– – 0.51% 41
2019
Q1 		$15.7M Sell
7,720
-5,790
-43% -$10.2M 0.64% 35
2018
Q4 		$17.4M Hold
13,510
– – 0.64% 32
2018
Q3 		$25.6M Buy
13,510
+386
+3% +$797K 0.66% 23
2018
Q2 		$26.7M Buy
13,124
+1,544
+13% +$3.52M 0.57% 22
2018
Q1 		$25.6M Hold
11,580
– – 0.32% 27
2017
Q4 		$26.7M Buy
11,580
+1,158
+11% +$2.35M 0.4% 22
2017
Q3 		$18.5M Sell
10,422
-8,878
-46% -$12.4M 0.32% 25
2017
Q2 		$26.3M Hold
19,300
– – 0.46% 18
2017
Q1 		$22.7M Sell
19,300
-13,320
-41% -$13.6M 0.5% 18
2016
Q4 		$26.1M Buy
32,620
+2,898
+10% +$2.3M 0.58% 19
2016
Q3 		$26.1M Sell
29,722
-5,018
-14% -$3.63M 0.52% 22
2016
Q2 		$19.5M Sell
34,740
-3,860
-10% -$2.19M 0.4% 18
2016
Q1 		$21.3M Buy
38,600
+10,808
+39% +$6.64M 0.41% 20
2015
Q4 		$23.1M Buy
27,792
+3,474
+14% +$3.47M 0.43% 28
2015
Q3 		$26.9M Buy
24,318
+8,878
+58% +$16.2M 0.6% 26
2015
Q2 		$33.7M Sell
15,440
-11,580
-43% -$23.6M 1.45% 18
2015
Q1 		$42.3M Buy
27,020
+5,790
+27% +$7.64M 1.95% 15
2014
Q4 		$25.2M Buy
21,230
+1,930
+10% +$1.29M 0.89% 26
2014
Q3 		$8.97M Hold
19,300
– – 0.33% 47
2014
Q2 		$9.64M Buy
19,300
+7,720
+67% +$2.47M 0.39% 51
2014
Q1 		$3.41M Hold
11,580
– – 0.12% 81
2013
Q4 		$3.15M Hold
11,580
– – 0.11% 70
2013
Q3 		$4.04M Buy
+11,580
New +$4.3M 0.13% 63

Other funds holding BLUE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artal Group's BLUE Position: Q2 2020 in Review

Artal Group sold out of bluebird bio (BLUE) in Q2 2020, closing a stake of 7,720 shares — an estimated $4.6M sold.

Artal Group first reported a position in BLUE in Q3 2013 and held it in 27 quarters. The position peaked at $42.3M in Q1 2015. 278 funds tracked by Wall St. Rank hold BLUE as of Q2 2020.

  • Artal Group reported no remaining bluebird bio position as of Q2 2020 after selling out during the quarter.
  • Artal Group sold 7,720 bluebird bio shares in Q2 2020, an estimated $4.6M.
  • Artal Group first reported a position in bluebird bio in Q3 2013 and held it in 27 quarters.
  • Artal Group's bluebird bio position peaked at $42.3M in Q1 2015.
  • 278 funds tracked by Wall St. Rank held bluebird bio as of Q2 2020.

Based on Artal Group's 13F filing for Q2 2020, filed 14 Aug 2020.